Filing Details
- Accession Number:
- 0001181431-14-023658
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-11 17:37:37
- Reporting Period:
- 2014-06-09
- Filing Date:
- 2014-06-11
- Accepted Time:
- 2014-06-11 17:37:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1070336 | Achillion Pharmaceuticals Inc | ACHN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1452429 | Joseph Truitt | C/O Achillion Pharmaceuticals 300 George Street New Haven CT 06511 | Evp, Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-06-09 | 1,050 | $0.82 | 1,050 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-06-09 | 1,050 | $4.82 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-06-10 | 48,950 | $0.82 | 48,950 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-06-10 | 48,950 | $6.05 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2014-06-09 | 1,050 | $0.00 | 1,050 | $0.82 |
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2014-06-10 | 48,950 | $0.00 | 48,950 | $0.82 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
98,950 | 2019-01-05 | No | 4 | M | Direct | |
50,000 | 2019-01-05 | No | 4 | M | Direct |
Footnotes
- This option was granted on January 5, 2009 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.